Neonatal hyperglycemia is one of the most common metabolic abnormalities encountered in
preterm and critically ill newborns. Although the definition varies, a blood glucose
concentration greater than 125 mg/dL (6.9 mmol/L) or a plasma or serum glucose
concentration greater than 150 mg/dL (8.3 mmol/L) often is used. Management of
hyperglycemia is highly variable, probably because of the lack of evidence for improved
outcomes in most neonates with any specific approach. This review focuses on the risk …